Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,16459,71,1.78 [1.25-2.52],0.0011970185053651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,16237,71,2.83 [1.45-5.51],0.00222854316425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,16390,71,2.45 [1.36-4.40],0.0027051631877043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,16629,72,3.95 [2.85-5.48],1.5728214442360263e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,16601,71,3.19 [1.70-5.98],0.0002981990884048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,16679,72,2.72 [1.96-3.79],3.0421387682758422e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,16337,70,1.51 [1.11-2.07],0.0088824770214352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,14076,62,3.41 [2.16-5.37],1.219087214957421e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,16740,73,14.39 [5.73-36.15],1.4106362277625776e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,13856,60,1.71 [1.37-2.13],1.5640510877370888e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,16459,71,1.76 [1.26-2.45],0.0009051432645577
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,16630,73,2.88 [2.31-3.60],8.049033183838222e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,16355,69,1.93 [1.19-3.15],0.0081899271391948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,16187,69,1.68 [1.30-2.17],7.910178546948504e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,16155,71,1.70 [1.32-2.20],4.519362400275611e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",16601,71,8.12 [4.58-14.40],8.02382473427078e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,14421,64,1.80 [1.54-2.11],2.0894607462833442e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,14372,64,2.16 [1.81-2.58],1.0858092586238879e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,14445,64,0.69 [0.53-0.90],0.0055096580689323
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,14009,59,3.47 [2.93-4.12],1.165487191057076e-46
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,14009,59,2.49 [1.65-3.75],1.267969561092994e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C2,Complement C2,16597,72,0.41 [0.21-0.79],0.0081143891539773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,14421,64,3.03 [2.36-3.91],8.181618405133747e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,16462,72,10.31 [3.88-27.36],2.8050365202483223e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,16419,71,1.54 [1.11-2.13],0.0096102033411886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,14178,64,0.74 [0.61-0.90],0.002874000976846
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,14413,64,1.56 [1.30-1.88],2.076498038612272e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,16512,71,0.72 [0.57-0.92],0.0070098031686556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,16497,71,1.56 [1.33-1.84],5.9433372059137014e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,16627,72,0.73 [0.59-0.89],0.0021026319619665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,16427,71,0.63 [0.48-0.82],0.0006856308234829
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,16515,69,0.47 [0.31-0.70],0.0002483802527128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,14178,64,3.22 [1.61-6.43],0.0009353716064758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,16525,73,1.32 [1.10-1.58],0.0031392646587364
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,16598,73,4.21 [1.81-9.81],0.0008401463169029
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,16497,71,19.73 [10.82-35.96],2.1631766578548463e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,16703,73,2.64 [2.10-3.33],1.152938918022357e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,16598,73,6.21 [4.56-8.46],4.649703273606035e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,16187,69,2.19 [1.65-2.89],4.0858683038661664e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,14149,63,2.94 [1.42-6.11],0.003805898220956
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,16478,71,2.71 [1.54-4.76],0.0005197055121857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,16576,71,18.93 [11.78-30.44],6.409263407182191e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,16661,73,5.63 [4.68-6.77],1.0290349159243162e-74
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,14383,62,0.31 [0.18-0.53],1.5791184126998264e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,16678,73,5.07 [3.57-7.20],9.746371570158089e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,16497,71,7.10 [5.37-9.39],4.060435431323324e-43
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,14149,63,9.97 [7.15-13.92],1.0466285246569959e-41
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,16661,72,6.69 [4.40-10.17],6.464410280000144e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,16703,73,6.38 [5.14-7.93],3.248102351286068e-63
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,14431,63,11.55 [7.47-17.87],3.561785795111161e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,16497,71,5.42 [3.41-8.62],9.947918111630062e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,14372,64,4.47 [2.57-7.78],1.1543709214732721e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,16661,72,1.64 [1.15-2.34],0.0060869852225666
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",14421,64,2.31 [1.63-3.28],2.2760132885815976e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,16640,73,3.05 [2.13-4.37],1.2922055675869623e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,16522,73,0.55 [0.36-0.83],0.0042441328296802
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,14009,59,4.82 [2.94-7.89],4.147158445942627e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,16497,71,2.19 [1.48-3.26],0.0001051723540002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,14421,64,3.85 [2.36-6.30],6.994778054453827e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,16740,73,3.24 [1.51-6.94],0.0025259651279701
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,14431,63,3.07 [2.02-4.69],1.869138148842972e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,14397,62,2.77 [1.47-5.20],0.001545499896712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,16627,72,2.45 [1.61-3.72],3.0102382180241343e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,16160,68,2.19 [1.75-2.73],5.168766545611215e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,16601,71,6.01 [2.61-13.85],2.498826913286996e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,16390,71,3.78 [2.65-5.39],2.0382933853263722e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,16601,71,4.21 [2.18-8.11],1.7646059412929854e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,14451,64,2.62 [1.61-4.28],0.0001164174337456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,16315,70,1.87 [1.21-2.90],0.0049221743658509
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,16522,72,5.11 [2.48-10.50],9.29514195911972e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,14279,63,1.90 [1.56-2.32],2.0975839647369714e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,16661,72,1.41 [1.15-1.73],0.0009397117755462
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,16538,71,0.70 [0.57-0.86],0.0007590613188281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,16472,72,0.74 [0.62-0.89],0.001169379591101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,14219,63,2.80 [2.10-3.73],2.6559063902241785e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,16522,72,3.71 [2.09-6.59],7.519862465629376e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,16661,72,4.62 [2.09-10.19],0.0001536325200963
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,13994,60,1.78 [1.41-2.24],1.3087232847046129e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,14386,64,1.80 [1.34-2.42],0.0001105775138984
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,16390,71,1.59 [1.18-2.13],0.0020613943000622
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,16459,71,4.09 [2.23-7.49],5.200666219532556e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,16630,73,1.51 [1.14-2.01],0.0044912629771377
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,14413,64,3.13 [1.68-5.84],0.0003230133994164
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,16459,71,6.18 [3.62-10.56],2.4307198337797165e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,16659,73,2.52 [1.32-4.81],0.0052076236888424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,16362,71,8.30 [5.84-11.80],4.3772634179296e-32
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,16187,69,0.35 [0.19-0.63],0.0005014748374677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,16497,71,1.70 [1.43-2.03],4.0558436679352144e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,16459,71,2.19 [1.92-2.51],3.843275936224265e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,16740,73,6.98 [2.98-16.39],7.942572497463508e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,13973,61,2.95 [1.70-5.11],0.0001202948335795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,16740,73,3.53 [1.72-7.23],0.0005591125764734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,14076,62,1.77 [1.30-2.41],0.0002766562731635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,15959,69,2.50 [1.56-4.01],0.0001528920855872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,14149,63,4.88 [2.16-11.01],0.0001336461305526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,16361,71,4.48 [2.57-7.80],1.197324268933928e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,16497,71,1.55 [1.26-1.90],2.4922406422957608e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,16660,73,3.61 [2.09-6.22],3.884256729594903e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,16361,71,0.66 [0.49-0.89],0.0070880991420176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,14178,64,3.07 [2.05-4.60],4.957337917319399e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,16661,72,9.22 [6.47-13.14],1.1745742467077194e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,14431,63,1.74 [1.27-2.39],0.0005386188558974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,16187,69,1.66 [1.30-2.12],5.548705678599862e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,16522,72,6.71 [5.58-8.06],5.2882841111893696e-92
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,16619,73,5.71 [4.95-6.58],7.61825172199843e-127
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,16244,70,6.10 [5.04-7.38],1.643406809051568e-77
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,16551,73,5.30 [4.08-6.88],5.006465102749413e-36
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,16187,69,1.43 [1.12-1.84],0.0043643328060735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,16187,69,1.53 [1.31-1.79],1.2117390699424992e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,16497,71,1.91 [1.47-2.49],1.4644063381916376e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,16164,69,3.55 [2.74-4.60],1.006431537408304e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,16244,70,2.70 [1.91-3.82],1.692163315268133e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,14431,63,2.40 [1.28-4.50],0.0062240420381768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,16459,71,11.78 [4.43-31.31],7.70942079085737e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,13812,57,1.69 [1.24-2.32],0.0010536380460606
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,16522,72,0.43 [0.24-0.78],0.0056405236863215
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,16659,73,2.60 [1.35-5.00],0.0041985854327122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,16187,69,0.66 [0.53-0.82],0.0001722222593252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,14386,64,1.79 [1.41-2.26],1.6512512973330222e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,14149,63,0.45 [0.24-0.82],0.0091663090597072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,16155,71,2.04 [1.46-2.85],2.823099308658715e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,16473,72,14.03 [8.11-24.28],3.711250841344263e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,16703,73,2.59 [1.70-3.94],8.791328957956138e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,16237,71,1.37 [1.14-1.64],0.0006055634475197
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,16551,73,2.42 [1.45-4.03],0.0007151082933379
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,16631,73,0.62 [0.46-0.82],0.0010543670281881
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,14421,64,2.08 [1.63-2.65],4.054207110809133e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",16497,71,2.27 [1.25-4.12],0.0071453279196312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,16155,71,1.63 [1.19-2.22],0.0020395917022988
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,14413,64,2.19 [1.77-2.72],1.0880226431846428e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,16689,73,1.82 [1.25-2.64],0.0017220931725395
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,16493,71,3.20 [1.73-5.92],0.0002067892480114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,16740,73,29.21 [19.18-44.50],1.2207907621428054e-55
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,16459,71,9.26 [3.38-25.33],1.463058921376586e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,14007,64,3.24 [2.16-4.85],1.1424817640811614e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,16601,71,3.14 [1.57-6.28],0.0012035152698653
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,16497,71,2.52 [1.96-3.25],9.527347404296058e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,16551,73,5.84 [2.58-13.23],2.281216119614115e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,16459,71,9.45 [7.50-11.90],8.19939543869659e-81
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,16244,70,1.41 [1.19-1.68],8.650215997399026e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,16601,71,2.15 [1.33-3.46],0.0016775477781385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,16459,71,1.70 [1.35-2.15],7.161644558855619e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,16703,73,2.01 [1.40-2.88],0.0001494546592052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,16244,70,2.71 [1.74-4.23],1.0987506655420892e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,14009,59,2.26 [1.44-3.55],0.0003762978440844
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,16244,70,2.27 [1.26-4.08],0.0065450830944878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,16703,73,2.41 [1.82-3.19],6.30358606416451e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,16627,72,3.80 [2.27-6.38],4.207871327652296e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,16414,71,5.16 [3.56-7.48],4.0250707870243294e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,14386,64,1.77 [1.22-2.56],0.002664498628827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,16497,71,3.81 [2.75-5.29],1.2132127539253113e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,16497,71,0.47 [0.31-0.69],0.0001549530305516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,16497,71,0.49 [0.35-0.70],7.62750924297995e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,16133,70,1.59 [1.22-2.07],0.0005318486958205
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,16126,71,2.05 [1.70-2.47],2.89025278869809e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",14076,62,2.43 [1.69-3.51],2.008403177507879e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",16237,71,1.41 [1.16-1.70],0.0005026027189664
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,16497,71,0.52 [0.32-0.84],0.0071084547755654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,14009,59,3.36 [1.82-6.19],0.0001036170461392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,13994,60,0.34 [0.16-0.71],0.0041389274283667
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,14064,63,0.37 [0.20-0.69],0.0018294560209866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,14158,62,2.25 [1.70-2.99],1.7948711735384983e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,16155,71,2.26 [1.28-4.01],0.0050137641923674
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,14421,64,2.14 [1.32-3.45],0.001887711530398
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,16546,73,0.47 [0.27-0.80],0.0059802639433935
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,16703,73,2.11 [1.27-3.49],0.0036558883242106
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,14421,64,1.77 [1.24-2.53],0.001703266282012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,16598,73,8.22 [4.63-14.61],6.858367080501837e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,16459,71,2.84 [1.98-4.08],1.6118157362222784e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,16522,71,1.90 [1.21-2.98],0.0052414490912477
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,16361,71,2.28 [1.37-3.78],0.0014828026207553
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,14431,63,0.50 [0.35-0.73],0.0003065205269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,16740,73,9.19 [4.66-18.11],1.5022416098746172e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,13973,61,1.51 [1.11-2.06],0.0083226072119687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,14460,64,3.44 [1.50-7.92],0.0036411662958554
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,14372,64,5.06 [2.98-8.57],1.8341843219947638e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,16497,71,5.28 [3.72-7.50],1.5540175900655262e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,16497,71,2.99 [2.49-3.58],5.845290395144054e-32
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,16497,71,4.58 [2.52-8.30],5.499644623914551e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,16324,73,26.43 [18.21-38.36],1.5552923029240036e-66
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,16390,71,0.35 [0.19-0.66],0.0010998295517806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,16187,69,1.67 [1.42-1.96],2.8374805793825405e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,16155,71,0.40 [0.21-0.77],0.005444850026495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,16187,69,1.49 [1.14-1.96],0.0036454134006084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,16327,71,1.76 [1.43-2.17],9.69554428776978e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",14076,62,6.95 [2.70-17.90],5.841893973744489e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,14421,64,2.45 [1.84-3.28],1.2627469911250482e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,13939,61,1.79 [1.30-2.45],0.0003162321405889
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,16522,72,3.29 [1.51-7.18],0.0027128375646246
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,16627,72,2.34 [1.36-4.02],0.0021521938279201
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,14421,64,2.64 [1.78-3.93],1.6564707266287776e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,14413,64,1.51 [1.14-1.99],0.0035892632748519
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,16575,71,0.51 [0.34-0.77],0.0012655694064247
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,14149,63,6.08 [2.78-13.29],5.937504471117749e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,16244,70,1.97 [1.70-2.27],3.28402219420013e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,16187,69,2.82 [2.17-3.67],1.0603776117299476e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,13973,61,2.16 [1.67-2.80],5.7116040291697125e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,16390,71,1.79 [1.58-2.02],1.1663733749043534e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,16740,73,37.33 [12.39-112.45],1.2442674810087813e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,14195,59,2.43 [1.41-4.21],0.0014457125728084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,16522,72,4.25 [2.33-7.77],2.54544507191696e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,16459,71,2.92 [1.68-5.08],0.0001479376295084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,16551,73,0.32 [0.15-0.68],0.0032867479063366
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,16497,71,2.06 [1.85-2.30],2.309623474797799e-40
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,16522,72,2.04 [1.19-3.47],0.009119307352553
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,14372,64,4.43 [2.52-7.78],2.38004074874123e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,16660,73,3.63 [2.94-4.47],2.156636663171703e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,16601,71,0.71 [0.56-0.90],0.0046435897569454
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,16497,71,2.45 [1.91-3.15],2.102218702934552e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,16551,73,3.03 [1.70-5.41],0.0001689487627556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,14064,63,1.95 [1.52-2.50],1.0979674257906757e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,13994,60,1.75 [1.24-2.47],0.0015302743128628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",16459,71,2.60 [2.04-3.32],1.2704011391371152e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,14360,64,0.66 [0.50-0.87],0.002994625742663
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,16187,69,1.86 [1.60-2.16],8.676087638060119e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,16187,69,1.72 [1.30-2.28],0.000136066113272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,14076,62,2.90 [1.63-5.16],0.0002761669983901
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,16497,71,1.91 [1.64-2.22],3.018999109753272e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,16497,71,1.69 [1.16-2.47],0.0067914957059603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,14009,59,1.58 [1.12-2.22],0.0087941942847504
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,16497,71,0.74 [0.59-0.93],0.0096373288593456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,16439,71,2.85 [1.77-4.57],1.5268186021781865e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,16155,71,0.48 [0.30-0.75],0.0014523759656043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,16390,71,1.43 [1.12-1.83],0.0038015821579972
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,14445,64,17.22 [10.03-29.55],5.248087220257533e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,16740,73,6.20 [2.87-13.38],3.3731715902611587e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,16079,70,1.61 [1.17-2.23],0.0038726967433651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,14386,64,1.75 [1.31-2.35],0.0001673448283254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,16187,69,1.75 [1.47-2.10],7.614019565690113e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,16129,71,1.82 [1.23-2.70],0.0027236613007481
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,13973,61,1.67 [1.23-2.26],0.0010470097140512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,16551,73,2.64 [1.44-4.83],0.0016754702430947
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,14341,62,1.73 [1.16-2.58],0.0071177837758659
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,16674,72,2.62 [1.47-4.67],0.0010925553230827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,14076,62,2.29 [1.34-3.90],0.0024875075293731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,16550,71,4.65 [2.48-8.74],1.74452400413069e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,16522,72,6.89 [3.77-12.58],3.304869610420512e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,14076,62,2.83 [2.15-3.72],8.9909224620668e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,14386,64,1.47 [1.11-1.95],0.0065009723996465
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,14413,64,2.37 [1.71-3.28],2.1791334956525322e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,13973,61,2.36 [1.89-2.94],2.448209799045937e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,16522,72,0.32 [0.21-0.48],3.1541175755387586e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,14149,63,3.93 [3.33-4.65],1.3448819179765513e-57
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,14460,64,17.72 [11.63-27.01],8.05139788816552e-41
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,14149,63,2.18 [1.40-3.37],0.0005017682139168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,16702,73,8.18 [6.44-10.38],1.0387267439586668e-66
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,16459,71,2.55 [1.64-3.96],3.208039901539338e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,16703,73,1.49 [1.19-1.87],0.0004290818807703
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,16337,70,2.43 [1.42-4.15],0.0012077141194032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,16497,71,13.74 [10.29-18.34],9.988614975277378e-71
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,16551,73,1.58 [1.22-2.04],0.0004850846074787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,16689,73,7.24 [5.39-9.72],1.2965239873200348e-39
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,14076,62,2.04 [1.20-3.45],0.0081401709805265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,14009,59,1.30 [1.06-1.58],0.0099442284099665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,16244,70,1.99 [1.38-2.86],0.0002124245058793
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,16187,69,7.99 [6.27-10.18],1.7655235482802582e-63
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,16187,69,1.86 [1.26-2.74],0.001727645907303
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,16689,73,2.07 [1.26-3.41],0.004025301173321
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,14372,64,2.16 [1.87-2.48],6.49841137810142e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,14386,64,0.48 [0.28-0.82],0.0068065825092735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',14421,64,1.87 [1.58-2.22],8.59522491436247e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,13973,61,1.57 [1.23-1.99],0.000228382265947
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,14431,63,2.50 [1.33-4.70],0.0043169387855916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,16507,72,5.22 [2.79-9.79],2.522189204799016e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,16390,71,0.32 [0.14-0.73],0.0068332006958388
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,13939,61,1.50 [1.17-1.92],0.001489824879317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",13994,60,2.96 [2.12-4.12],1.3423191269173987e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,16459,71,2.67 [2.18-3.27],1.6260187220975329e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",16459,71,1.72 [1.21-2.46],0.002753615395844
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,16661,72,6.47 [5.39-7.77],3.0966631306865704e-89
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,16534,73,4.35 [1.81-10.45],0.0010030261832877
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,14372,64,2.64 [2.03-3.45],8.878308401744152e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,14178,64,0.38 [0.21-0.71],0.0022524006932776
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,14421,64,1.73 [1.26-2.37],0.0006895490167794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,16373,71,3.00 [2.62-3.43],3.3574615920519584e-57
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,14431,63,3.64 [2.87-4.62],1.4980314918843158e-26
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,14386,64,1.69 [1.41-2.03],2.6020841889904654e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,16598,73,4.98 [2.09-11.90],0.0002975156927047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,16621,72,2.45 [1.54-3.91],0.0001691629492387
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,14451,64,4.35 [2.09-9.03],8.278410464985627e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,16522,72,2.72 [1.88-3.93],1.0763656785686069e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,16435,72,2.08 [1.19-3.64],0.0097881831264484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,16740,73,3.22 [1.58-6.56],0.0012633131823525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",16126,71,1.98 [1.43-2.75],3.668308278010441e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,14178,64,1.67 [1.28-2.17],0.0001378350271968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,16627,72,3.01 [2.04-4.45],3.4009891564536335e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,16212,71,1.79 [1.36-2.36],2.880744412199344e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,16390,71,2.40 [1.66-3.48],3.754808721740204e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,16390,71,1.51 [1.25-1.82],1.703469332328457e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,16550,71,5.99 [4.84-7.42],8.961038167711283e-61
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,16244,70,6.15 [3.88-9.75],1.0799693184001736e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,14149,63,3.15 [1.81-5.47],4.957324136763261e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,16551,73,2.28 [1.27-4.10],0.0057333336513702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,16551,73,1.78 [1.36-2.35],3.326712064431864e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,16678,73,4.84 [3.36-6.96],1.9627899239920938e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,16661,72,2.22 [1.57-3.15],7.011128307447489e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,16390,71,4.69 [3.90-5.64],8.813977141758922e-61
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,16601,71,0.43 [0.25-0.72],0.0016480177725815
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,16720,73,0.40 [0.27-0.59],5.678490834171765e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,14445,64,3.30 [2.14-5.10],7.398025890644867e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,14009,59,1.67 [1.28-2.18],0.0001756368502473
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,16187,69,2.13 [1.39-3.25],0.0004894797864918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,14009,59,1.73 [1.35-2.24],2.074455288845872e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,14431,63,4.11 [1.84-9.18],0.0005618031368166
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,13973,61,1.76 [1.42-2.17],1.4600764894016394e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",14009,59,1.98 [1.30-3.01],0.0013564525122799
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,16551,73,10.52 [6.89-16.06],1.0643213344166317e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,16390,71,2.37 [1.48-3.77],0.0002918870629992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,14421,64,2.54 [1.95-3.31],4.245804206276252e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,16597,72,3.65 [1.88-7.09],0.0001340345701873
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,16740,73,1.45 [1.10-1.91],0.008389161160944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,14386,64,3.51 [2.89-4.25],5.350335824776018e-37
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,14386,64,2.13 [1.26-3.59],0.0047315153522825
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,14009,59,2.42 [1.78-3.30],1.8830599901195e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,16237,71,2.25 [1.84-2.73],8.078219675171478e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,14421,64,2.70 [2.25-3.23],5.7149579794642236e-27
